Sang‐Woo Hahn

826 total citations
45 papers, 589 citations indexed

About

Sang‐Woo Hahn is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Sang‐Woo Hahn has authored 45 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 13 papers in Pharmacology and 13 papers in Clinical Psychology. Recurrent topics in Sang‐Woo Hahn's work include Bipolar Disorder and Treatment (11 papers), Treatment of Major Depression (11 papers) and Tryptophan and brain disorders (7 papers). Sang‐Woo Hahn is often cited by papers focused on Bipolar Disorder and Treatment (11 papers), Treatment of Major Depression (11 papers) and Tryptophan and brain disorders (7 papers). Sang‐Woo Hahn collaborates with scholars based in South Korea, Japan and United States. Sang‐Woo Hahn's co-authors include Seung‐Hwan Lee, Min Jin Jin, Min‐Soo Lee, Yong‐Ku Kim, Wookyoung Jung, Rhee-Hun Kang, Myoung-Jin Choi, Kyoung‐Sae Na, Jong‐Woo Paik and Bun-Hee Lee and has published in prestigious journals such as Journal of Affective Disorders, Frontiers in Psychology and Schizophrenia Research.

In The Last Decade

Sang‐Woo Hahn

42 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sang‐Woo Hahn South Korea 15 172 148 112 93 91 45 589
Xiangyang Zhang China 16 231 1.3× 141 1.0× 131 1.2× 52 0.6× 111 1.2× 61 632
Jerónimo Sáiz Ruiz Spain 12 285 1.7× 134 0.9× 58 0.5× 95 1.0× 73 0.8× 37 569
Camilla Bock Denmark 13 193 1.1× 227 1.5× 78 0.7× 122 1.3× 134 1.5× 15 696
Alexander Brunnauer Germany 12 181 1.1× 80 0.5× 74 0.7× 102 1.1× 72 0.8× 44 556
Mary-Jane Attenburrow United Kingdom 14 191 1.1× 88 0.6× 127 1.1× 93 1.0× 79 0.9× 28 631
Harlyn Aizley United States 11 246 1.4× 156 1.1× 135 1.2× 72 0.8× 38 0.4× 16 599
Vasilios G. Masdrakis Greece 14 248 1.4× 126 0.9× 55 0.5× 142 1.5× 57 0.6× 45 535
A. Tadić Germany 10 185 1.1× 168 1.1× 158 1.4× 145 1.6× 86 0.9× 17 624
Dorottya Pap Hungary 16 165 1.0× 148 1.0× 125 1.1× 91 1.0× 88 1.0× 34 623
Francisco Romo‐Nava United States 15 185 1.1× 116 0.8× 60 0.5× 38 0.4× 70 0.8× 40 658

Countries citing papers authored by Sang‐Woo Hahn

Since Specialization
Citations

This map shows the geographic impact of Sang‐Woo Hahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sang‐Woo Hahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sang‐Woo Hahn more than expected).

Fields of papers citing papers by Sang‐Woo Hahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sang‐Woo Hahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sang‐Woo Hahn. The network helps show where Sang‐Woo Hahn may publish in the future.

Co-authorship network of co-authors of Sang‐Woo Hahn

This figure shows the co-authorship network connecting the top 25 collaborators of Sang‐Woo Hahn. A scholar is included among the top collaborators of Sang‐Woo Hahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sang‐Woo Hahn. Sang‐Woo Hahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hwang, Jaeuk, et al.. (2023). Impulsivity in Major Depressive Disorder Patients with Suicidal Ideation: Event-related Potentials in a GoNogo Task. Clinical Psychopharmacology and Neuroscience. 21(4). 787–797. 6 indexed citations
2.
Hahn, Sang‐Woo, et al.. (2023). Development of Prediction Model for Suicide Attempts Using the Korean Youth Health Behavior Web-Based Survey in Korean Middle and High School Students. Journal of Korean Neuropsychiatric Association. 62(3). 95–95.
3.
Hwang, Jaeuk, et al.. (2022). The Mediating Role of Depression Severity on the Relationship Between Suicidal Ideation and Self-Injury in Adolescents With Major Depressive Disorder. Journal of korean Academy of Child and Adolescent Psychiatry. 33(4). 99–105. 3 indexed citations
4.
5.
Hwang, Jaeuk, et al.. (2021). Relationship Between the Loudness Dependence of the Auditory Evoked Potential and the Severity of Suicidal Ideation in Patients with Major Depressive Disorder. Clinical Psychopharmacology and Neuroscience. 19(2). 323–333. 8 indexed citations
6.
7.
Park, Seon‐Cheol, Hwa-Young Lee, Dong Woo Lee, et al.. (2015). Knowledge and Attitude of 851 Nursing Personnel toward Depression in General Hospitals of Korea. Journal of Korean Medical Science. 30(7). 953–953. 12 indexed citations
8.
Hahn, Sang‐Woo, et al.. (2015). A Qualitative Content Analysis of Reports of Mental Health Service Providers After the Sewol Ferry Accident in Korea. Mental Health & Social Work. 43(4). 116–144. 10 indexed citations
9.
Park, Jin-Wan, et al.. (2015). Influence of Depression on Working Memory Measured by Digit Backward Span in the Subjects with Mild Cognitive Impairment and Dementia. 19(2). 79–85. 1 indexed citations
10.
Won, Eunsoo, Seon‐Cheol Park, Kyu‐Man Han, et al.. (2014). Evidence-Based, Pharmacological Treatment Guideline for Depression in Korea, Revised Edition. Journal of Korean Medical Science. 29(4). 468–468. 8 indexed citations
11.
Lee, Jae-Hon, Sang‐Woo Hahn, Ik‐Seung Chee, et al.. (2014). Clinical Characteristics of Panic Disorder Patients in Korean University Hospital : A Multi-Center, Retrospective Study. 10(1). 11–16.
12.
Park, Seon‐Cheol, Sang‐Woo Hahn, Tae-Yeon Hwang, et al.. (2014). Does Age at Onset of First Major Depressive Episode Indicate the Subtype of Major Depressive Disorder?: The Clinical Research Center for Depression Study. Yonsei Medical Journal. 55(6). 1712–1712. 38 indexed citations
13.
Kim, Yong‐Ku, Jung-A Hwang, Heon‐Jeong Lee, et al.. (2014). Association between norepinephrine transporter gene (SLC6A2) polymorphisms and suicide in patients with major depressive disorder. Journal of Affective Disorders. 158. 127–132. 19 indexed citations
14.
Pae, Chi‐Un, Hong Jin Jeon, Boung Chul Lee, et al.. (2013). Aripiprazole augmentation for treatment of patients with chronic or recurrent major depressive disorder. International Clinical Psychopharmacology. 28(6). 322–329. 9 indexed citations
15.
Park, Seon‐Cheol, et al.. (2013). A General Hospital-Based Model for Early Detection of Depression in the Geriatric Patients with Chronic Medical Diseases. 20(2). 31–39. 1 indexed citations
16.
Kim, JW, et al.. (2013). Association between Characteristics of Brain Magnetic Resonance Imaging and Atypical Antipsychotics Use in Dementia Patients. 20(3). 97–103. 1 indexed citations
17.
Park, Jong‐Il, Donghwan Cho, Sang‐Woo Hahn, et al.. (2013). The advantage of using 3-week data to predict response to aripiprazole at week 6 in first-episode psychosis. International Clinical Psychopharmacology. 29(2). 77–85. 11 indexed citations
18.
Kim, Leen, et al.. (2011). Association between Somatic Component of the Hamilton Depression Rating Scale and the Plasma ACTH & Serum Cortisol Level in Korean Patients with Major Depressive Disorder. 17(2). 205–210. 1 indexed citations
19.
Ham, Byung‐Joo, et al.. (2010). Trial of aripiprazole in the treatment of first‐episode schizophrenia. Psychiatry and Clinical Neurosciences. 64(1). 38–43. 14 indexed citations
20.
Lee, Seung‐Hwan, et al.. (2007). Facial affect perception and event-related potential N170 in schizophrenia: A preliminary study. Clinical Psychopharmacology and Neuroscience. 5(2). 76–80. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiangyang Zhang Breakdown of academic impact, for papers by Jerónimo Sáiz Ruiz Breakdown of academic impact, for papers by Camilla Bock Breakdown of academic impact, for papers by Alexander Brunnauer Breakdown of academic impact, for papers by Mary-Jane Attenburrow Breakdown of academic impact, for papers by Harlyn Aizley Breakdown of academic impact, for papers by Vasilios G. Masdrakis Breakdown of academic impact, for papers by A. Tadić Breakdown of academic impact, for papers by Dorottya Pap Breakdown of academic impact, for papers by Francisco Romo‐Nava
Rankless by CCL
2026